Prolexys Pharmaceuticals Initiates Phase 1 Study
SALT LAKE CITY, Aug. 29 /PRNewswire/ -- prolexys
today announced that its fir...nalog of a compound called erastin,
in-licensed by prolexys
from the MIT/ Whitehead Institute in January 2005....6, 2003).
Extensive medicinal chemistry efforts at prolexys
resulted in the discovery
of PRLX 93936, a small m...
Prolexys Pharmaceuticals and Columbia University Researchers
Publish Study on Anti-Tumor Properties of a Selective Small
Molecule Anti-Tumor Agent With Novel Mechanism of Action
...elective small molecule anti-tumor agent,
and Columbia applied the company's
chemi-proteomic...t of , and the
Whitehead Institute, which provides prolexys
worldwide rights to a patent estat...a novel cell death pathway," said Dr. Stockwell.
launched a medicinal chemistry effort in 2005 to c...
Prolexys in Biological News
Prolexys in Biological Technology